SELLAS Life Sciences Soars: Revolutionary Cancer Treatment Data Ignites Stock
Telomir Pharmaceuticals Stock Soars 35% on Groundbreaking Preclinical Data
Serina Therapeutics Stock Skyrockets: Unpacking the 37% Surge Driven by Breakthrough Preclinical Data